Ocrelizumab (EU) clinical trials

Comparison Between ABP 692 and Ocrevus® (Ocrelizumab)

This study compares a new medicine, ABP 692, with an existing one, Ocrevus, for people with a type of multiple sclerosis (RRMS). It checks if special brain scans and how the medicines act in the body are similar, aiming to offer another treatment option.